The hemolysis inhibition assay is a sensitive technique that evaluates the ability of a test agent to block complement cell lysis. In this assay, red blood cells serve as targets and are exposed to serum with complement proteins. Inhibitors reduce cell destruction, allowing measurement of inhibition. This method is used for investigating complement activity, diagnosing deficiencies, and supporting therapeutic development by offering a rapid, precise analysis of complement function successfully.